After Vaccines Row, Sanofi Invests In France, Macron To Secure Supplies

CEO Restates Commitment To France

Sanofi’s €610m investment helps row to be forgotten – though Macron will ‘place bets’ on several COVID-19 vaccines, not just France’s homegrown candidate.

Sanofi_Berlin
Sanofi is investing more than €600m in two sites near Lyon, France

Sanofi is to expand its vaccines manufacturing and build a new research center in its home market of France, as its CEO Paul Hudson looks to move on from a row over its COVID-19 vaccine candidate.

British-born Hudson got into hot water with political leaders in France last month when he said the US had earned...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip